Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. daily Stock Chart
Pfizer Inc.
IndexDJIA S&P500 P/E17.94 EPS (ttm)2.05 Insider Own0.03% Shs Outstand5.56B Perf Week-0.60%
Market Cap204.07B Forward P/E13.06 EPS next Y2.81 Insider Trans-9.32% Shs Float5.53B Perf Month5.22%
Income11.84B PEG3.79 EPS next Q0.62 Inst Own74.80% Short Float1.00% Perf Quarter-15.98%
Sales53.66B P/S3.80 EPS this Y-11.90% Inst Trans-0.56% Short Ratio2.15 Perf Half Y-12.33%
Book/sh10.71 P/B3.43 EPS next Y-0.28% ROA7.90% Target Price41.82 Perf Year-15.19%
Cash/sh2.32 P/C15.80 EPS next 5Y4.73% ROE20.00% 52W Range33.97 - 46.47 Perf YTD-15.95%
Dividend1.44 P/FCF49.40 EPS past 5Y1.00% ROI10.20% 52W High-21.05% Beta0.65
Dividend %3.92% Quick Ratio1.20 Sales past 5Y0.80% Gross Margin80.10% 52W Low8.01% ATR0.68
Employees92400 Current Ratio1.50 Sales Q/Q-1.50% Oper. Margin23.30% RSI (14)45.79 Volatility1.53% 1.93%
OptionableYes Debt/Eq0.78 EPS Q/Q36.80% Profit Margin23.60% Rel Volume1.61 Prev Close36.51
ShortableYes LT Debt/Eq0.61 EarningsOct 29 BMO Payout62.80% Avg Volume25.71M Price36.69
Recom2.50 SMA201.72% SMA50-3.10% SMA200-10.91% Volume41,457,021 Change0.49%
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
Sep-21-19 09:02AM  NFL legend Terry Bradshaw buys and sells $5 million planes the way some people flip houses MarketWatch
Sep-20-19 10:02AM  Walgreens Boots, Pfizer share gains contribute to Dow's nearly 75-point jump MarketWatch
08:41AM  Pharma Stock Roundup: FDA Approves Expanded Use of MRK/J&J's Drugs & Other Updates Zacks
Sep-19-19 05:21PM  5 Companies Growing Earnings
09:10AM  Pfizer Is Spinning Off Upjohn. Whats Left Will Be No Bargain, Analyst Says
07:38AM  Pfizer Presents Scientific Advancements in Cancer Care at the ESMO Congress 2019 Highlighting Expanded Portfolio Business Wire
Sep-18-19 10:41AM  Merck's Keytruda Combo Gets FDA Nod for Endometrial Carcinoma Zacks
Sep-17-19 10:00AM  Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call With Analysts Business Wire
01:00AM  Our Ultimate Stock-Pickers' Top 10 Dividend-Yielding Stocks Morningstar
Sep-16-19 05:45PM  Pfizer (PFE) Stock Moves -0.24%: What You Should Know Zacks
02:33PM  Ex-FDA commissioner Gottlieb wants to keep his Boston speech 'off-the-record' American City Business Journals
08:33AM  Breast Cancer Drugs May Inflame Lungs Per FDA Safety Alert Zacks
Sep-13-19 09:46AM  Pharma Stock Roundup: Pipeline/Regulatory Updates From GSK, PFE & Others Zacks
09:36AM  Renal Cell Carcinoma Space in Focus: Some Key Developments Zacks
Sep-12-19 05:46PM  Gilead Tops List of Most Innovative Drug Companies
Sep-11-19 04:53PM  5 Companies Growing Earnings
04:15PM  Dow Jones Today: Plenty of Good News InvestorPlace
03:50PM  Leaner Pfizer Positioned to Boost R&D Output
09:32AM  4 Big Drugmakers Boasting Impressive Oncology Pipelines Zacks
04:00AM  Merck KGaA lung cancer drug is 3rd on U.S. watchdog's priority lane Reuters
Sep-10-19 06:06PM  Pfizer's Pneumococcal Vaccine Shows Potential in Infants Zacks
05:45PM  Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know Zacks
04:15PM  Pelosi Drug Pricing Plan Puts Big Pharma In 2020 Election Hot Seat Investor's Business Daily
11:41AM  ACADIA Surges on Early Success of Nuplazid Dementia Study Zacks
11:18AM  Aveo CEO says new data eases concerns about troubled kidney cancer drug American City Business Journals
10:55AM  10 Healthcare Stocks to Buy Despite the Headlines InvestorPlace
10:00AM  Merck, Pfizer Slide on Pelosis Scary Drug-Pricing Plan Bloomberg
Sep-09-19 09:24AM  Stocks To Buy: Is It Time To Buy Or Sell These Large-Cap Stocks? Investor's Business Daily
08:00AM  Pfizer Announces Positive Preliminary Results from a Proof-of-Concept Phase 2 Study (B7471003) of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Otitis Media in Healthy Infants Business Wire
Sep-08-19 11:02AM  Top 4 Mutual Fund Holders of Pfizer Investopedia
Sep-06-19 11:57AM  Pfizer is a Top Drugmaker: Is it the Right Time to Buy It? Zacks
02:24AM  UPDATE 1-Novartis joins Pfizer with FDA fast-track tag for lung cancer hopeful Reuters
Sep-05-19 04:51PM  3 Special Situations Gurus Are Buying
10:18AM  J&J's Stelara Gets Approval in EU for Ulcerative Colitis Zacks
09:36AM  Merck's Keytruda Combination Gets EC Nod for Kidney Cancer Zacks
09:00AM  Pfizer Stock Is A Top Pharma Company But Should You Buy It? Investor's Business Daily
Sep-04-19 05:45PM  Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know Zacks
02:54PM  Why a Spanish joint venture is paying off for a Triangle company American City Business Journals
10:00AM  AbbVie Stock Is Poised To Become A Top 5 Pharma But Should You Buy It? Investor's Business Daily
Sep-03-19 08:45AM  Global Blood Focuses on Lead Candidate Amid Competition Zacks
Sep-02-19 07:51AM  Here's Why Glaxo (GSK) Steadily Stays Ahead of Its Industry Zacks
Aug-30-19 05:21PM  Mass Pig Deaths in China Cause Short Supply of U.S. Blood Thinner Bloomberg
Aug-29-19 01:10PM  Ronald Muhlenkamp's Firm Buys 2 Stocks in 2nd Quarter
09:06AM  Forget Pfizer, Add These Big Drugmakers to Your Portfolio Zacks
Aug-28-19 05:39PM  US Indexes Rebound to Close Higher Wednesday
10:52AM  Stock Market Suddenly Shrugging off Yield-Curve Inversion
10:45AM  Dow's 100-point jump highlighted by gains in shares of UnitedHealth, Nike MarketWatch
10:38AM  The Zacks Analyst Blog Highlights: Bristol-Myers Squibb Company, Celgene, Exact Sciences, Pfizer and Guardant Health Zacks
10:10AM  Here's Why Merck (MRK) is Outperforming Its Industry Of Late Zacks
09:30AM  Pfizer (PFE) Down 11.5% Since Last Earnings Report: Can It Rebound? Zacks
01:00AM  10 Superior Dividend Stocks Morningstar
Aug-27-19 06:25PM  US Indexes Close Lower Tuesday
02:58PM  9 Hot Stocks to Buy Now InvestorPlace
11:01AM  4 Biotech Stocks to Buy That Are on the Move InvestorPlace
09:24AM  3 Cancer Treatment Stocks to Enrich Your Portfolio Zacks
06:00AM  Why Jim Cramer's Negative Take on Pfizer Is Flat-Out Wrong Motley Fool
Aug-26-19 11:57AM  52-Week Company Lows
Aug-24-19 01:46PM  10 Biopharmaceutical Companies Trying To Cure Cancer Benzinga
Aug-23-19 09:58AM  'It's a little 'Star Trekky'': How this S.F. startup looks to create 3D-printed organs American City Business Journals
09:40AM  Pharma Stock Roundup: ABBV's Rinvoq Gets FDA Nod, BAYRY to Sell Animal Health Unit Zacks
Aug-22-19 03:54PM  Boeing, JPMorgan Chase share gains lead Dow's 132-point jump MarketWatch
12:10PM  Health insurers will expand ACA coverage in 2020 Yahoo Finance Video
11:08AM  Jim Cramer Weighs In On Pfizer, Teva And More Benzinga
10:20AM  Pfizer's Xtandi Label Expansion Filing Gets Priority Review Zacks
10:07AM  Glaxo Submits First Regulatory Application for Daprodustat Zacks
07:30AM  3 Dividend Stocks That Pay Better Than Coca-Cola Motley Fool
Aug-21-19 04:14PM  Pfizer Digs Deeper Into Gene Therapy, Rivaling These Biotech Stocks Investor's Business Daily
04:10PM  Record Stock Buybacks Fueled by Debt and Cash
02:00PM  U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer Business Wire
12:27PM  Pfizer invests $500 million in expanding gene therapy facility Reuters
11:04AM  Teva Launches Generic Version of Mylan's EpiPen for KIds Zacks
10:50AM  AstraZeneca's Imfinzi Fails in Stage IV Lung Cancer Study Zacks
10:01AM  Pfizer invests $500 million in expanding gene therapy facility Reuters
10:00AM  Pfizer to build $500M facility in Sanford, create hundreds of jobs American City Business Journals
10:00AM  Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina Business Wire
09:20AM  Trade of the Day: Pfizer Stock Is Flashing Attractive Buy Signals InvestorPlace
08:56AM  Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco Zacks
Aug-20-19 06:38PM  Bayer Sells Animal Health Division to Elanco: Now What? Zacks
03:55PM  Dow's 150-point drop led by losses for Dow Inc., American Express stocks MarketWatch
03:11PM  3 Healthcare Stocks to Trade: UNH, JNJ and PFE InvestorPlace
02:48PM  Pfizer-backed cancer treatment innovator SpringWorks eyes $115M IPO American City Business Journals
01:54PM  3 Great Active Mutual Funds for the Current Environment InvestorPlace
01:34PM  Dow Inc., American Express share losses contribute to Dow's nearly 75-point drop MarketWatch
12:02PM  Parents Push One Rare-Disease Drug Through FDA, Not Its Successor Bloomberg
10:45AM  Sarepta Stock Falls as FDA Denies Approval to Golodirsen Zacks
10:09AM  Exelixis (EXEL) Stock Up 15.2% YTD on Strong Cabometyx Sales Zacks
07:00AM  The Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance Business Wire
Aug-19-19 02:45PM  Obesity Epidemic Leads To A New Problem And It Could Be Worth Billions Investor's Business Daily
08:58AM  Solid Biosciences Surges on DMD Gene Therapy Study Amendments Zacks
07:58AM  Pfizer (NYSE:PFE) Shareholders Have Enjoyed A 20% Share Price Gain Simply Wall St.
Aug-18-19 06:16PM  52-Week Company Lows
Aug-17-19 12:22PM  Market Volatility Got You Nervous? The Merger Fund Might Be the Answer
Aug-16-19 04:25PM  How AbbVie Plans To Take On Pfizer, Lilly And Kick Its Humira Habit Investor's Business Daily
11:28AM  Pharma Stock Roundup: Pipeline/Regulatory Updates From JNJ, LLY, AZN, RHHBY Zacks
Aug-15-19 03:36PM  The Top Pharma Stocks for 2019 Investopedia
02:41PM  Sarepta's Lone Analyst Skeptic Takes On 22 Bulls With Renewed Warnings Bloomberg
01:26PM  Pfizer recalls two lots of migraine drug due to potential bacterial contamination MarketWatch
11:54AM  10 Cheap Dividend Stocks to Load Up On InvestorPlace
07:48AM  Merck's Cancer Immunotherapy Keytruda Continues to Aid Growth Zacks
05:55AM  Bain executive joins biotech startup Cerevel's C-suite American City Business Journals
Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases under the Lyrica, Chantix/Champix, Eliquis, Ibrance, Sutent, Xalkori, Inlyta, Xtandi, Enbrel, Xeljanz, Eucrisa, BeneFix, Genotropin, and Refacto AF/Xyntha brands. The company also provides consumer healthcare products that comprise over-the-counter medicines, including dietary supplement products under the Centrum, Caltrate, and Emergen-C names; pain management products under the Advil and ThermaCare names; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H names; and respiratory and personal care products under the Robitussin, Advil Cold & Sinus, and ChapStick names. In addition, it offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit, Ixifi Infliximab BS names. Further, the company is also involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Oncolytics Biotech Inc.; licensing agreement with BionTech AG; strategic alliance with Verily Life Sciences LLC; and collaboration agreements with Pfizer, Merck & Co., Inc., and Eli Lilly & Company, as well as Merck KGaA, Nektar Therapeutics, and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PFIZER INC10% OwnerSep 17Buy18.0050,000900,0004,593,847Sep 19 04:19 PM
Gottlieb ScottDirectorAug 23Buy34.723,000104,1603,000Aug 26 09:27 AM
DAMELIO FRANK AExecutive Vice PresidentJul 02Sale44.09153,1846,753,385337,392Jul 03 04:06 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentJun 20Sale44.0030,0001,320,00080,094Jun 21 04:08 PM
PFIZER INC10% OwnerMay 13Buy17.0050,000850,0003,249,973May 14 07:34 AM
MACKENZIE ALEXANDER RExecutive Vice PresidentApr 01Sale42.8315,000642,503110,094Apr 02 03:05 PM
JOHNSON RADY AExecutive Vice PresidentMar 15Sale41.138,700357,83159,797Mar 18 06:37 PM
READ IAN CExecutive ChairmanMar 04Sale43.2950,7882,198,4741,639,280Mar 06 04:03 PM
READ IAN CExecutive ChairmanMar 04Sale43.17530,07822,882,7021,109,202Mar 06 04:03 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.268,725377,444172,094Mar 06 03:29 PM
SUSMAN SALLYExecutive Vice PresidentMar 04Sale43.1463,9982,760,698108,096Mar 06 03:29 PM
ROGERS DAWNExecutive Vice PresidentMar 04Sale42.9815,002644,79814,920Mar 05 04:55 PM
Dolsten MikaelPresident R&DMar 04Sale43.5249,0822,136,293289,126Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Option Exercise31.34106,1913,328,057438,679Mar 05 04:54 PM
Dolsten MikaelPresident R&DMar 01Sale43.56100,4714,376,852338,208Mar 05 04:54 PM
ROGERS DAWNExecutive Vice PresidentFeb 27Option Exercise32.2319,297621,94245,049Mar 01 07:47 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise32.2385,7632,764,141228,743Mar 01 07:47 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise32.23154,3744,975,474441,923Mar 01 07:47 PM
GOETTLER MICHAELGroup PresidentFeb 27Option Exercise32.2330,017967,44848,652Mar 01 07:37 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise32.2311,792380,05623,635Mar 01 07:37 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise32.2330,017967,44881,341Mar 01 07:37 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise32.2364,3222,073,098123,145Mar 01 07:37 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 27Option Exercise32.2381,4752,625,939416,278Mar 01 07:37 PM
BOURLA ALBERTChief Executive OfficerFeb 27Option Exercise32.2364,3222,073,098331,982Mar 01 07:29 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 27Option Exercise32.2325,729829,246121,743Mar 01 07:29 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise32.23182,2475,873,821588,177Mar 01 07:29 PM
YOUNG JOHN DGroup PresidentFeb 23Option Exercise21.0343,724919,516312,403Feb 26 07:45 PM
JOHNSON RADY AExecutive Vice PresidentFeb 23Option Exercise21.0318,004378,62461,182Feb 26 07:45 PM
BOURLA ALBERTChief Executive OfficerFeb 23Option Exercise21.0336,008757,248191,438Feb 26 07:45 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 23Option Exercise21.0387,4491,839,052388,024Feb 26 07:45 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 23Option Exercise21.03185,1853,894,441522,576Feb 26 07:45 PM
SUSMAN SALLYExecutive Vice PresidentFeb 23Option Exercise21.0397,7372,055,409205,833Feb 26 07:46 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 23Option Exercise21.0343,724919,51683,781Feb 26 07:45 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 23Option Exercise21.0341,615875,163144,164Feb 26 07:10 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 23Option Exercise21.0330,864649,070115,139Feb 26 07:10 PM
ROGERS DAWNExecutive Vice PresidentFeb 23Option Exercise21.0319,290405,66937,638Feb 26 07:10 PM
GOETTLER MICHAELGroup PresidentFeb 23Option Exercise21.0319,290405,66931,507Feb 26 07:11 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 01Sale42.755,000213,75040,057Feb 01 07:21 PM
Dolsten MikaelPresident R&DJan 31Option Exercise29.78125,9683,751,425362,051Feb 01 07:28 PM
LANKLER DOUGLAS MExecutive Vice PresidentJan 30Sale41.1938,8001,598,07145,057Feb 01 07:21 PM
READ IAN CChairman & CEONov 02Option Exercise26.641,100,20129,312,5881,760,958Nov 06 03:46 PM
PFIZER INC10% OwnerOct 15Buy18.0055,5561,000,00822,032,040Oct 17 05:17 PM